Caxton Associates (UK)’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Sell
56,928
-57,281
-50% -$1.47M 0.03% 298
2026
Q1
$2.67M Sell
114,209
-292,334
-72% -$5.29M 0.06% 152
2025
Q4
$5.77M Buy
406,543
+281,541
+225% +$5.33M 0.11% 55
2025
Q3
$3.1M Sell
125,002
-48,480
-28% -$1.08M 0.07% 123
2025
Q2
$3.94M Buy
173,482
+160,482
+1,234% +$3.8M 0.1% 104
2025
Q1
$394K Buy
+13,000
New +$495K 0.01% 549

Other funds holding ACHC

Caxton Associates (UK)'s ACHC Position: Q2 2026 in Review

Caxton Associates (UK) reduced its Acadia Healthcare (ACHC) stake by 50% in Q2 2026, selling an estimated $1.47M and leaving 56,928 shares worth $1.68M. The position accounts for 0.03% of the portfolio, ranked #298.

Caxton Associates (UK) first reported a position in ACHC in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.77M in Q4 2025. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Caxton Associates (UK) held 56,928 shares of Acadia Healthcare worth $1.68M as of Q2 2026.
  • Caxton Associates (UK) sold 57,281 Acadia Healthcare shares in Q2 2026, an estimated $1.47M.
  • Acadia Healthcare made up 0.03% of Caxton Associates (UK)'s portfolio in Q2 2026, its #298 holding.
  • Caxton Associates (UK) first reported a position in Acadia Healthcare in Q1 2025 and has held it in 6 quarters since.
  • Caxton Associates (UK)'s Acadia Healthcare position peaked at $5.77M in Q4 2025.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.